Professor John Fraser AO Presents at the Food Allergy Fund Innovation & Investment Summit

In April 2025, Professor John Fraser AO, Founder and Chief Medical Officer of DMC had the privilege of presenting at the prestigious Food Allergy Fund Summit in New York. John shared the progress being made on DMC’s Epinephrine Inhaler that is currently in development, targeting rapid treatment of Anaphylaxis.

 

Watch the full presentation here.